Precancerous lesions in the cirrhotic et non-cirrhotic liver;Les lésions précancéreuses sur foie cirrhotique et non cirrhotique

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 5 SUPPL., 2004, Pages

  Blanc, Jean Frédéric ^a,b   Bioulac Sage, Paulette ^b,c   Trillaud, Hervé ^a   Zucman Rossi, Jessica ^d   Balabaud, Charles ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; CHEMOKINE; CHEMOKINE LIGAND 12; CONNEXIN 26; CYCLIN DEPENDENT KINASE 2; DNA TOPOISOMERASE (ATP HYDROLYSING); GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; MONOCLONAL ANTIBODY KI 67; PLASMINOGEN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN B; TELOMERASE REVERSE TRANSCRIPTASE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

A2M GENE; CANCER RISK; CDKN2A GENE; CJB2 GENE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CXCL12 GENE; DIAGNOSTIC IMAGING; GENE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; IGF2 GENE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MKI67 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PDGFRA GENE; PLG GENE; POLYMERASE CHAIN REACTION; PRECANCER; SCREENING TEST; TERT GENE; THBS1 GENE; TIE2 GENE; TLAM1 GENE; TOP2A GENE; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MASS SCREENING; PRECANCEROUS CONDITIONS;

EID: 3042633524     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (92)

1. Tratner I. De l'efficacité de la politique de prévention et de dépistage dans la lutte contre le cancer. Médecine/Sciences 2003;19:368-70.
2. Bouvier AM, Remontet L, Estève J, Faivre J. Estimation de l'incidence nationale des cancers du foie en 2000 et de son évolution depuis 20 ans (abstract). Gastroenterol Clin Biol 2003;27:A72.
3. Okuda K. Hepatocellular carcinoma: recent progress. J Hepatol 2002;32:225-37.
4. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-5.
5. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
6. Le Bail B, Bernard PH, Caries J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997;27:835-42.
7. Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: Precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996;111:1587-92.
8. Sherman M. Alphafetoprotein: an orbituary. J Hepatol 2001;34:603-5.
9. Giardina MG, Matarazzo M, Morante R, Lucariello A, Varriale A, Guardasole V, et al. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer 1998;83:2468-74.
10. Mita Y, Aoyagi Y, Yanagi M, Suda T, Suzuki Y, Asakura J. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma. Cancer 1998;82:1643-8.
11. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology 2003;37:1114-21.
12. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
13. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61-6.
14. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994;21:1029-34.
15. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
16. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-85.
17. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
18. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
19. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23:1112-8.
20. Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003;37:520-7.
21. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-60.
22. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, et al. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers 2001;17:179-89.
23. Bioulac-Sage P, Bedossa P, Guettier C. Lésions hépatocytaires précancéreuses. In: Pathologie hépatique tumorale. Groupe METAVIR. Elsevier (ed) 2002,45-58.
24. Le Bail B, Bioulac-Sage P, Tran Van Nhieu J, Zafrani ES. Approche actuelle de la carcinogenèse hépatique. De la cirrhose au carcinome hépatocellulaire. Ann Pathol 1995;15:332-47.
25. Paradis V, Dargere D, Bonvoust F, Rubbia-Brandt L, Ba N, Bioulac-Sage P, et al. Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest 2000;80:1553-9.
26. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998;115:1216-22.
27. Borzio M, Bruno S, Roncalli M, Colloredo Mels G, Ramella G, Borzio F, Leandro G, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis. A prospective study. Gastroenterology 1994;108:812-17.
28. Guettier C, Ganne-Carrié N, Ziol M, Arotcarena R, Christidis C, Beaugrand M. Comment et pourquoi rechercher la dysplasie hépatocytaire à grandes cellules sur ponction-biopsie hépatique? Ann Pathol 2001;21:137-44.
29. Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 2001;39:66-73.
30. Scoazec JY. Dysplasie hépatocytaire: lésions pré- ou péricancéreuse? Gastroenterol Clin Biol 1999;23:433-7.
31. Anthony PP, Vogel CL, and Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973;26:217-23.
32. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J, et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 2001;32:327-32.
33. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, et al. Morphologic studies of the liver cell dysplasia. Cancer 1983;51:2197-205.
34. Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993;18:1363-9.
35. Bannasch P, Haertel T, Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003;31:134-9.
36. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003;31:126-33.
37. Shibata M, Morizane T, Uchida T, Yamagami T, Onozuka Y, Nakano M, et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 1998;351:1773-7.
38. Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002;6:497-512.
39. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
40. Le Bail B, Belleannée G, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P. Adenomatous hyperplasia in cirrhotic livers, histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 100 adults French patients. Hum Pathol 1995;26:897-906.
41. Borzio M, Fargion S, Borzio F, Francanzani AL, Croce AM, Stoffolini S, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003 (in press).
42. Borzio M, Trere D, Borzio F, Ferrari AR, Bruno S, Roncalli M, et al. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol Pathol 1998;51:96-101.
43. Park YN, Chae KJ, Kim YB, Park C, Theise N. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer 2001;92:2733-8.
44. Donato MF, Arosio E, Monti V, Fasani P, Prati D, Sangiovanni A, et al. Proliferating cell nuclear antigen assessed by a computer-assisted image nalysis system in patients with chronic viral hepatitis and cirrhosis. Dig Liver Dis 2002;34:197-203.
45. Frachon S, Gouysse G, Dumortier J, Couvelard A, Nejjari M, Mion F, et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol 2001;34:850-7.
46. Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi F, Minola E, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999;5:1174-8.
47. Trere D, Borzio M, Morabito A, Borzio F, Roncalli M, Derenzini M. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection. Hepatology 2003;37:72-8.
48. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999;19:287-96.
49. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-4.
50. Bioulac-Sage P, Le Bail B, Winnock M, Balabaud C, Bernard C, Blanc JF, et al. Occurrence of hepatocellular carcinoma in nonfibrotic livers. Hepatology 2000;32:1411-2.
51. Blanc JF, De Ledinghen V, Trimoulet P, Le Bail B, Bernard PH, Saric J, et al. Premalignant lesions and hepatocellular carcinoma in a noncirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol 1999;30:325-9.
52. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 1999;213:352-61.
53. Gossmann J, Scheuermann EH, Frilling A, Geiger H, Dietrich CF. Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type la (von Gierke disease). Transplantation 2001;72:343-4.
54. Scott FR, el-Refaie A, More L, Scheuer PJ, Dhillon AP. Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology 1996;28:472-4.
55. Ferrell LD. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 1993;17:525-9.
56. Murakami T, Mochizuki K, Nakamura H. Imaging evaluation of the cirrhotic liver. Semin Liver Dis 2001;21:213-24.
57. Tsuchiyama T, Terasaki S, Kaneko S, Kaji K, Kobayashi K, Matsui O. Tiny staining spots in liver cirrhosis associated with HCV infection observed by computed tomographic hepatic arteriography: follow-up study. J Gastroenterol 2002;37:807-14.
58. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (< or = 2cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003;226:550-5.
59. Kanematsu M, Hoshi H, Yamada T, Murakami T, Kim T, Kato M, et al. Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings. Abdom Imaging 1999;24:47-55.
60. Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, et al. Differential diagnosis of small hepatocellular carcinoma and borderline lesions and therapeutic strategy. Hepatogastroenterology 2002;49:1591-6.
61. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61.
62. Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 2002;179:75-80.
63. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 2001;34:1109-12.
64. Krinsky GA, Lee VS, Nguyen MT, Rofsky NM, Theise ND, Morgan GR, et al. Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 2000;24:773-6.
65. Krinsky GA, Nguyen MT, Lee VS, Rosen RJ, Goldenberg A, Theise ND, et al. Dysplastic nodules and hepatocellular carcinoma: sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation. J Comput Assist Tomogr 2000;24:628-34.
66. Tanaka Y, Sasaki Y, Katayama K, Hiramatsu N, Ito A, Murata H, et al. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography. Hepatology 2000;31:890-8.
67. Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, et al. Hepatocellular carcinoma: detection with triple-phase multidetector row helical CT in patients with chronic hepatitis. Radiology 2003;226:543-9.
68. Noguchi Y, Murakami T, Kim T, Hori M, Osuga K, Kawata S, et al. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase. J Comput Assist Tomogr 2002;26:981-7.
69. Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, et al. Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 2003;42:14-21.
70. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000;10:185-200.
71. Bluteau O, Laurent-Puig P. Zucman-Rossi J. Genetic alterations in hepatocellular carcinomas: associations with clinical parameters. Gastroenterol Clin Biol 2001;25:1067-77.
72. Aihara T, Noguchi S, Sasaki Y, Nakano H, Monden M, Imaoka S. Clonal analysis of precancerous lesion of hepatocellular carcinoma. Gastroenterology 1996;111:455-61.
73. Kim JW, Wang XW. Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis 2003;24:363-9.
74. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763-73.
75. Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernheim A, et al. Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene 2000;19:3733-8.
76. Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P. et al. Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene 2002;21:1225-32.
77. Paradis V, Bièche I, Dargère D, Laurendeau I, Laurent C, Bioulac Sage P, et al. Molecular profiling of hepatocellular carcinoma (HCC) using large scale real-time RT-PCR approach: determination of a molecular index. Am J Pathol 2003 (in press).
78. van Dekken H, Wink J, Alers JC, de Man RA, IJzermans JN, Zondervan PE. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature. Acta Histochem 2003;105:29-41.
79. Kishimoto Y, Shiota G, Wada K, Kitano M, Nakamoto K, Kamisaki Y, et al. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma. J Cancer Res Clin Oncol 1996;122:585-9.
80. Roncalli M, Bianchi P, Grimaldi GC, Ricci D, Laghi L, Maggioni M, et al. Fractional allelic loss in non-end-stage cirrhosis: Correlations with hepatocellular carcinoma development during followup. Hepatology 2000;31:846-50.
81. Maggioni M, Coggi G, Cassani B, Bianchi P, Romagnoli S, Mandelli A, et al. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 2000;32:942-6.
82. Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001;121:699-709.
83. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Am J Pathol 1999;154:37-43.
84. Zondervan PE, Wink J, Alers JC, Ijzermans JN, Schalm SW, de Man RA, et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 2000;192:207-15.
85. Marchio A, Terris B, Meddeb M, Pineau P, Duverger A, Tiollais P, et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridization. Mol Pathol 2001;54:270-4.
86. Tornillo L, Carafa V, Sauter G, Moch H, Minola E, Gambacorta M, et al. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: High-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 2002;82:547-53.
87. Nasarek A, Wemer M, Nolte M, Klempnauer J, Georgii A. Trisomy 1 and 8 occur frequently in hepatocellular carcinoma, but not in liver cell adenoma and focal nodular. Virchows Arch 1995;427:373-8.
88. Terris B, Ingster O, Rubbia L, Dubois S, Belghiti J, Feldmann G, et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 1997;27:313-9.
89. Wilkens L, Bredt M, Flemming P, Becker T, Klemphauer J, Kreipe HH. Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001;193:476-82.
90. Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002;32:312-5.
91. Hadengue A. Dépistage du carcinome hépatocellulaire: entre cynisme et angélisme? Gastroentérol Clin Biol 2003;27:525-7.
92. Sherman M. Hepatocellular carcinoma: beyond screening. J Hepatol 2003;39:269-71.